Principal Financial Group Inc. reduced its stake in shares of Livent Co. (NYSE:LTHM) by 18.4% during the 3rd quarter, according to its most recent filing with the SEC. The firm owned 1,273,721 shares of the company’s stock after selling 287,411 shares during the period. Principal Financial Group Inc. owned approximately 0.79% of Livent worth $29,435,000 at the end of the most recent quarter.
Several other large investors have also bought and sold shares of LTHM. Grantham Mayo Van Otterloo & Co. LLC grew its position in shares of Livent by 317.2% during the 2nd quarter. Grantham Mayo Van Otterloo & Co. LLC now owns 1,982,067 shares of the company’s stock valued at $38,373,000 after acquiring an additional 1,507,012 shares during the period. Vanguard Group Inc. boosted its holdings in Livent by 7.8% in the 2nd quarter. Vanguard Group Inc. now owns 17,061,497 shares of the company’s stock worth $330,310,000 after buying an additional 1,241,572 shares during the last quarter. Amundi acquired a new stake in Livent in the 2nd quarter worth about $16,096,000. Allianz Asset Management GmbH boosted its holdings in Livent by 56.4% in the 2nd quarter. Allianz Asset Management GmbH now owns 1,993,719 shares of the company’s stock worth $38,598,000 after buying an additional 719,152 shares during the last quarter. Finally, Marshall Wace North America L.P. purchased a new position in Livent in the 2nd quarter worth approximately $11,952,000. Hedge funds and other institutional investors own 94.06% of the company’s stock.
A number of research firms have weighed in on LTHM. TheStreet raised shares of Livent from a “d+” rating to a “c” rating in a research note on Monday, October 11th. Zacks Investment Research raised shares of Livent from a “hold” rating to a “buy” rating and set a $26.00 target price on the stock in a research note on Wednesday. Vertical Research raised shares of Livent from a “hold” rating to a “buy” rating and set a $30.00 target price on the stock in a research note on Tuesday, January 4th. Citigroup lowered shares of Livent from a “buy” rating to a “neutral” rating and set a $31.00 price target on the stock. in a research report on Tuesday, November 9th. Finally, Piper Sandler reduced their price target on shares of Livent from $34.00 to $31.00 in a research report on Tuesday. Two research analysts have rated the stock with a sell rating, four have issued a hold rating and eight have issued a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $26.64.
Livent (NYSE:LTHM) last issued its earnings results on Thursday, November 4th. The company reported $0.03 EPS for the quarter, missing analysts’ consensus estimates of $0.04 by ($0.01). The firm had revenue of $103.60 million for the quarter, compared to analyst estimates of $96.00 million. Livent had a positive return on equity of 2.22% and a negative net margin of 3.13%. The business’s revenue for the quarter was up 42.7% on a year-over-year basis. During the same quarter in the previous year, the firm posted ($0.05) EPS. On average, equities analysts forecast that Livent Co. will post 0.15 EPS for the current year.
Livent Company Profile
Livent Corp. engages in the production of performance lithium compounds. Its products include battery-grade lithium hydroxide, butyllithium, and purity lithium metal which are used in various performance applications. It operates through the following geographical segments: North America; Europe, Middle East, and Africa; Latin America; and Asia Pacific.
Recommended Story: Initial Coin Offering (ICO)
Want to see what other hedge funds are holding LTHM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Livent Co. (NYSE:LTHM).
Receive News & Ratings for Livent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Livent and related companies with MarketBeat.com's FREE daily email newsletter.